Sutro Biopharma (STRO) Equity Ratio (2017 - 2025)
Historic Equity Ratio for Sutro Biopharma (STRO) over the last 9 years, with Q3 2025 value amounting to 0.42.
- Sutro Biopharma's Equity Ratio fell 26909.77% to 0.42 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42, marking a year-over-year decrease of 26909.77%. This contributed to the annual value of 0.12 for FY2024, which is 6376.69% down from last year.
- According to the latest figures from Q3 2025, Sutro Biopharma's Equity Ratio is 0.42, which was down 26909.77% from 0.12 recorded in Q2 2025.
- In the past 5 years, Sutro Biopharma's Equity Ratio registered a high of 0.86 during Q1 2021, and its lowest value of 0.42 during Q3 2025.
- Over the past 5 years, Sutro Biopharma's median Equity Ratio value was 0.33 (recorded in 2023), while the average stood at 0.39.
- Per our database at Business Quant, Sutro Biopharma's Equity Ratio surged by 6069.32% in 2021 and then crashed by 26909.77% in 2025.
- Quarter analysis of 5 years shows Sutro Biopharma's Equity Ratio stood at 0.74 in 2021, then dropped by 27.9% to 0.53 in 2022, then crashed by 40.4% to 0.32 in 2023, then crashed by 63.77% to 0.12 in 2024, then crashed by 461.36% to 0.42 in 2025.
- Its Equity Ratio was 0.42 in Q3 2025, compared to 0.12 in Q2 2025 and 0.08 in Q1 2025.